Provider
P6-17 A New Drug, Emflaza (deflazacort), Will Require Prior Authorization
Program effective Date: Feb 27, 2017
Documents & Forms Results
Displaying 2981 - 2990 of 3100 results
Provider
2017 March Provider Press
Program effective Date: Feb 16, 2017
Provider
P5-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Program effective Date: Feb 08, 2017
Provider
P4-17 Addition of Drug to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Jan 30, 2017
Provider
P2-17 Updated: Change in Coverage for Detoxification Services for Minnesota Health Care Programs Subscribers
Program effective Date: Jan 27, 2017
Provider
P3-17 Added Reimbursement Policies
Program effective Date: Jan 27, 2017
Provider
P1-17 Prior Authorization Requirement for Gender Dysphoria
Program effective Date: Jan 18, 2017
Provider
QP1-17 2017 Commercial Network Guide
Program effective Date: Jan 09, 2017
Provider
P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents
Program effective Date: Dec 20, 2016
Provider
QP39-16 Digital Breast Tomosynthesis (DBT) for Routine Breast Cancer Screening
Program effective Date: Dec 15, 2016